Polymyalgia rheumatica is typically treated with glucocorticoids, but more than half of patients cannot successfully taper treatment, resulting in long-term glucocorticoid use and substantial glucocorticoid-related morbidity.
Read the full SAPHYR trial Research Summary:
No autoantibody has been implicated for GCA, but B-cells are abundant in the inflamed arteries. We show that B-cells may play a role in the amplification of inflammation in GCA by cytokines production and macrophage skewing. @JacolienGr @VasculitisUMCG
https://t.co/ZbFN53pGtn
New Research: Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients: Introduction
Giant cell arteritis (GCA) is a vasculitis of the medium- and large-sized arteries. Interferon type I (IFN-I) is… #immunology https://t.co/8jgoGxPsAC
CAR-T cell therapy for refractory #SLE.
♦️ Promising results in all 5 patients (SLADAI and fatigue)
♦️ Drug-free remission even if B cells recur.
♦️ Long lasting remission as per observation period of 22 months.
Tue Wenzel at #EULAR2023
@Janetbirdope@drdavidliew @SleenYannick @ElisabethBrouw3 @VasculitisUMCG You're right. However it's still quite under explored. If confirmed, senolytics or senomorphics may potentially be useful as alternative treatment strategies for these diseases. Hence, we think it's important to dive deeper into this topic.
GCA affects patients above 50 years old. Could senescence play a role in the immunopathology? Our data indicates yes. More research is needed to dive deeper into this topic. @SleenYannick @ElisabethBrouw3 @VasculitisUMCG https://t.co/CL506z5qs4
Liquid biopsy with urine biomarkers to assess treatment response in #LupusNephritis. CD206, CD163, and IL16 in the urine assc well with histologic activity by renal biopsy. #RheumGr@rheumnow
Interested in #giant#cell#arteritis? Check out our latest publication on #glucocorticoid treatment:
▶️ patients at onset showed a dysregulated lipid and glucose metabolism
▶️ glucocorticoid treatment related to increased risk of comorbidities
🔗 https://t.co/pTkPcI6UAx
So grateful to my wonderful co-authors, Dr Poh-Yi Gan, @Kim_M_OS, @KitchingLab and Prof Stephen Holdsworth on their support getting this paper published. I think Shaun would be very proud today!
https://t.co/4Ed9brf7iu
Tofacitinib in new-onset PMR:
Nice mechanistic data - all the right things line up - leading to promising proof-of-concept study (EAST PMR)
Plenty to tease apart here but real promise to explore in bigger studies
ABST1107 #ACR22@RheumNow
I've always presumed biopsy-neg GCA just hit skip lesions sections
What does RNA-Seq of temporal artery bx tell us?
positive bx similar to skip lesions
bx neg GCA very different
Sometimes it's not just the sampling
sometimes it's something different...
ABST0486 #ACR22@RheumNow
Presenting Slide-TCR-seq: our method for measuring the transcriptomes of cells & T cell receptor (TCR) sequences in situ!
This collaboration w/ Bryan Iorgulescu, Shuqiang Li, Catherine Wu, and @insitubiology led to some cool findings...
https://t.co/bamg5yCToX
1/8
After 2,5 years of online collaboration, the Immune-Image consortium will be reunited in Berlin for the annual meeting on 10 and 11 October! Two days of inspiring #workshops and interesting presentations. We are excited to see everyone!
#immunotherapy#ImmuneImageH2020
The VF is kicking off our annual fundraising efforts, and we are so excited to highlight our programs over the coming weeks. The VF works to support patients with vasculitis by providing them with resources and a community. We cannot do this crucial work without your support!